| Name | Title | Contact Details |
|---|---|---|
Arun Douglas |
Chief Technology and Security Officer | Profile |
Gregory Floyd |
Chief Information Security Officer | Profile |
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
Bio-Tissue®, a subsidiary of TissueTech™, is the leader in regenerative biologic therapies and ocular hygiene solutions for eye care professionals. Established in 1997, Bio-Tissue® serves an unmet need for better surgical and therapeutic alternatives for helping eye care professionals heal ocular surface conditions, such as keratitis, recurrent corneal erosions, conjunctivochalasis dry eye, pterygium and dry eye. Eye care professionals understand that good medicine is based on good science. Bio-Tissue® prides itself on developing products that meet the highest clinical standards, are based on quality research and scientific data, and provide innovative solutions for a range of ocular surface and lid margin diseases. Bio-Tissue® adheres to the FDA tissue and medical device guidelines.
Breathe Moore Easy is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Northwest Texas Healthcare System is a Amarillo, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PINNACLE CBO is a Lakewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.